Literature DB >> 8409764

Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat.

A C Rustan1, B E Hustvedt, C A Drevon.   

Abstract

Rats were fed lard or n-3 fatty acid-supplemented diets ad libitum to study whole body oxidation of lipid and carbohydrate. One group of male rats was fed 21% fat (by weight) containing 19.5% lard and sufficient amounts of essential fatty acids (1.5%). Another group of rats had 6.5% of the lard replaced by ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The rats were fed these diets for 6-8 weeks. Body weight gain was similar for the two groups and absorption of fat was complete in animals fed both types of fatty acids. Indirect calorimetric measurements, after 3-5 weeks on these diets, by continuous registration of O2 consumption and CO2 formation showed no difference in mean energy expenditure during the experimental period. However, the mean respiratory quotient (RQ) was significantly increased for animals fed the n-3 fatty acid-supplemented diet. This was noted both under fasting conditions and after receiving a test meal of similar fatty acid composition for both feeding groups. Thus, mean substrate utilization demonstrated reduced oxidation of fat and increased oxidation of carbohydrate, during fasting as well as fed periods for the n-3 fatty acid group as compared to the lard group. After an additional 2-3 weeks, blood plasma, liver, and muscle samples were collected, and adipocytes and hepatocytes were isolated. Reduced postprandial plasma concentrations of triacylglycerol, phospholipids, unesterified fatty acids, and glycerol were promoted by the n-3 fatty acid diet as compared to lard. Plasma concentration of glucose was slightly increased, and liver and muscle content of glycogen were decreased in the n-3 fatty acid-fed rats. Experiments with isolated adipocytes showed decreased basal lipolysis after feeding n-3 fatty acids for 6-8 weeks for suspended epididymal adipocytes, whereas stimulated lipolysis by isoproterenol (0.1 microM) was higher in both epididymal and mesenteric adipocytes from rats fed n-3 fatty acids as compared to animals fed lard. In addition, epididymal adipocytes from rats fed n-3 fatty acids were significantly smaller than cells from animals fed lard. Hepatic peroxisomal fatty acid oxidation was significantly higher for n-3 fatty acid-supplemented animals, but total fatty acid oxidation was similar in both dietary groups. The hepatic content of triacylglycerol and phospholipids was similar for both diets. These results demonstrate that n-3 fatty acid replacement of a high-fat diet containing mostly saturates and monoenes for several weeks promotes reduced use of fat as energy source. This may be explained by decreased plasma concentration of unesterified fatty acids.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409764

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Dietary fat source and cholesterol interactions alter plasma lipids and tissue susceptibility to oxidation in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats.

Authors:  Yvonne V Yuan; David D Kitts
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Fish oil -- how does it reduce plasma triglycerides?

Authors:  Gregory C Shearer; Olga V Savinova; William S Harris
Journal:  Biochim Biophys Acta       Date:  2011-10-25

3.  Fish oil prevents changes induced by a high-fat diet on metabolism and adipokine secretion in mice subcutaneous and visceral adipocytes.

Authors:  Roberta D C da Cunha de Sá; Amanda R Crisma; Maysa M Cruz; Amanda R Martins; Laureane N Masi; Catia L do Amaral; R Curi; Maria I C Alonso-Vale
Journal:  J Physiol       Date:  2016-08-25       Impact factor: 5.182

4.  Effects of dietary treatment of rats with eicosapentaenoic acid or docosahexaenoic acid on hepatic lipid metabolism.

Authors:  H Osmundsen; H Braud; F Beauseigneur; J Gresti; M Tsoko; P Clouet
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

5.  Enteral feeding a structured lipid emulsion containing fish oil prevents the fatty liver of sepsis.

Authors:  S Lanza-Jacoby; H Phetteplace; R Tripp
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

6.  The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression.

Authors:  J Ukropec; J E Reseland; D Gasperikova; E Demcakova; L Madsen; R K Berge; A C Rustan; I Klimes; C A Drevon; E Sebökova
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

7.  Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes.

Authors:  Elizabeth Manickam; Andrew J Sinclair; David Cameron-Smith
Journal:  Lipids Health Dis       Date:  2010-06-04       Impact factor: 3.876

8.  Dietary proteins modulate the effects of fish oil on triglyceridemia in the rat.

Authors:  I Demonty; Y Deshaies; H Jacques
Journal:  Lipids       Date:  1998-09       Impact factor: 1.880

9.  Effects of a diet enriched with polyunsaturated, saturated, or trans fatty acids on cytokine content in the liver, white adipose tissue, and skeletal muscle of adult mice.

Authors:  Bruno dos Santos; Debora Estadella; Ana Cláudia Losinskas Hachul; Marcos Hiromu Okuda; Mayara Franzoi Moreno; Lila Missae Oyama; Eliane Beraldi Ribeiro; Claudia Maria da Penha Oller do Nascimento
Journal:  Mediators Inflamm       Date:  2013-08-20       Impact factor: 4.711

10.  Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.

Authors:  Olga Horakova; Dasa Medrikova; Evert M van Schothorst; Annelies Bunschoten; Pavel Flachs; Vladimir Kus; Ondrej Kuda; Kristina Bardova; Petra Janovska; Michal Hensler; Martin Rossmeisl; Rui Wang-Sattler; Cornelia Prehn; Jerzy Adamski; Thomas Illig; Jaap Keijer; Jan Kopecky
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.